Immunomodulatory effects of glutamine-enriched nutritional support in elderly patients with severe sepsis: a prospective, randomized, controlled study

References

• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–55
   PubMed Web of Science ®Google Scholar
• Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34: 15–21
   PubMed Web of Science ®Google Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–10
   PubMed Web of Science ®Google Scholar
• Cheek DJ, McGehee-Smith H, Cunneen J, Cartwright M. Sepsis: taking a deeper look. Nursing 2005; 35: 38–42
   PubMedGoogle Scholar
• Bone RC. Why sepsis trials fail. JAMA 1996; 276: 565–6
   PubMed Web of Science ®Google Scholar
• Volk HD, Reinke P, Docke WD. Clinical aspects: from systemic inflammation to “immunoparalysis”. Chem Immunol 2000; 74: 162–77
   PubMedGoogle Scholar
• Volk HD, Thieme M, Heym S, Döcke WD, Ruppe U, Tausch W, et al. Alterations in function and phenotype of monocytes from patients with septic disease—predictive value and new therapeutic strategies. Behring Inst Mitt 1991; 88: 208–15
   Google Scholar
• Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27: 2799–805
   PubMed Web of Science ®Google Scholar
• Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944–53
   PubMed Web of Science ®Google Scholar
• Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30: 2022–9
   PubMed Web of Science ®Google Scholar
• Heuser MD, Adler WH. Immunological aspects of aging and malnutrition: consequences and intervention with nutritional immunomodulators. Clin Geriatr Med 1997; 13: 697–715
   PubMed Web of Science ®Google Scholar
• Sibbald WJ, Vincent JL. Round table conference on clinical trials for the treatment of sepsis. Crit Care Med 1995; 23: 394–9
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29
   PubMed Web of Science ®Google Scholar
• Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638–52
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536–55
   PubMed Web of Science ®Google Scholar
• Lacey JM, Wilmore DW. Is glutamine a conditional essential amino acid?. Nutr Rev 1990; 48: 297–309
   PubMed Web of Science ®Google Scholar
• Kelly D, Wischmeyer PE. Role of L-glutamine in critical illness: new insights. Curr Opin Clin Nutr Metab Care 2003; 6: 217–22
   PubMed Web of Science ®Google Scholar
• Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001; 90: 2403–10
   PubMed Web of Science ®Google Scholar
• Heyland DK, Novak F. Immunonutrition in the critically ill patient: more harm than good?. J Parenter Enteral Nutr 2001; 25: 51–6
   Web of Science ®Google Scholar
• Destarac LA, Ely EW. Sepsis in older patients: an emerging concern in critical care. Adv Sepsis 2002; 2: 15–22
   Google Scholar
• Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Jr, Hui JJ, Chang KC, et al. Sepsis induced apoptosis causes progressive profound depletion of B and CD4-T lymphocytes in humans. J Immunol 2001; 166: 6952–63
   PubMed Web of Science ®Google Scholar
• Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002; 18: 487–94
   PubMed Web of Science ®Google Scholar
• Perry SE, Mostafa SM, Wenstone R, Shenkin A, McLaughlin PJ. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?. Intensive Care Med 2003; 29: 1245–52
   PubMed Web of Science ®Google Scholar
• Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intensive Care Med 2000; 26(Suppl 1)S124–8
   PubMedGoogle Scholar
• Griffiths RD, Jones J, Palmer MD. Six-month outcome of critically ill patients given glutamine supplemented parenteral nutrition. Nutrition 1997; 13: 295–302
   PubMed Web of Science ®Google Scholar
• Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002; 30: 2032–7
   PubMed Web of Science ®Google Scholar
• Barbul A. Immunonutrition comes of age. Crit Care Med 2000; 28: 884–5
   PubMed Web of Science ®Google Scholar
• Oltermann MH, Rassas TN. Immunonutrition in a multidisciplinary ICU population: a review of the literature. J Parenter Enteral Nutr 2001; 25: S30–4
   PubMed Web of Science ®Google Scholar